Approval · Notice of Compliance 4245 · 1996
BROMAZEPAM: Notice of Compliance 4245
Issued May 24, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4245
- Date
- May 24, 1996
- Company
- Laboratoires Pro Doc Limitée
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anxiolytic, sedative
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BROMAZEPAM | 02220512 | Cancelled Post Market |
| BROMAZEPAM | 02220520 | Cancelled Post Market |
| BROMAZEPAM | 02220539 | Cancelled Post Market |
Medicinal ingredients
- BROMAZEPAM 1.5 MG per TAB
- BROMAZEPAM 3 MG per TAB
- BROMAZEPAM 6 MG per TAB